Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLIT with grass pollen allergen for children with grass pollen rhinoconjunctivitis
NL-OMON23382Active, not recruiting
- Sponsor
- Artu Biologicals
- Start
- Sep 2001
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised, triple-blind trial in allergic rhinoconjunctivitis (ARC) and grass pollen allergy comparing Oralgen Grass Pollen with Placebo (2 arms). Primary endpoint: Mean daily total symptom score. Started Sep 2001; status: active, not recruiting.
02
Drugs
Oralgen Grass Pollen
03
Conditions
allergic rhinoconjunctivitis (ARC)grass pollen allergy
Beyond the preview
Go deeper on NL-OMON23382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23382.